93
Views
0
CrossRef citations to date
0
Altmetric
ORIGINAL ARTICLE

Neurological soft signs and prepulse inhibition of the startle reflex in psychosis: A pilot study

, , , , , , , , , & show all
Pages 276-284 | Received 28 Apr 2014, Accepted 29 Jan 2015, Published online: 13 Mar 2015

References

  • Aggernaes B, Glenthoj BY, Ebdrup BH, Rasmussen H, Lublin H, Oranje B. 2010. Sensorimotor gating and habituation in antipsychotic-naive, first-episode schizophrenia patients before and after 6 months’ treatment with quetiapine. Int J Neuropsychopharmacol 13:1383–1395.
  • Amaddeo F, Tansella M. 2009. Information systems for mental health. Epidemiol Psichiatr Soc 18:1–4.
  • Arango C, Bartko JJ, Gold JM, Buchanan RW. 1999. Prediction of neuropsychological performance by neurological signs in schizophrenia. Am J Psychiatry 156:1349–1357.
  • Bachmann S, Bottmer C, Schröder J. 2005. Neurological soft signs in first-episode schizophrenia: a follow-up study. Am J Psychiatry 162:2337–2343.
  • Boks MP, Selten JP, Leask S, Van den Bosch RJ. 2006. The 2-year stability of neurological soft signs after a first episode of non-affective psychosis. Eur Psychiatry 21:288–290.
  • Bonora LI, Conti L, Piccinelli L, Tansella M, Cassano GB, Lecrubier Y. 1995. Mini International Neuropsychiatric Interview (Mini), Italian version, Le scale di valutazione in Psichiatria. In: Conti L, editor. Digest Neuropsichiatria Milano: Utet.
  • Braff DL, Grillon C, Geyer MA. 1992. Gating and habituation of the startle reflex in schizophrenic patients. Arch Gen Psychiatry 49:206–215.
  • Braff DL, Swerdlow NR, Geyer MA. 1999. Symptom correlates of prepulse inhibition deficits in male schizophrenic patients. Am J Psychiatry 156:596–602.
  • Buchanan RW, Heinrichs DW. 1989. The Neurological Evaluation Scale (NES): a structured instrument for the assessment of neurological signs in schizophrenia. Psychiatry Res. 27:335–350.
  • Cadenhead KS. 2011. Startle reactivity and prepulse inhibition in prodromal and early psychosis: effects of age, antipsychotics, tobacco and cannabis in a vulnerable population. Psychiatry Res 188:208–216.
  • Chan RC, Xu T, Heinrichs RW, Yu Y, Wang Y. 2010. Neurological soft signs in schizophrenia: a meta-analysis. Schizophr Bull 36:1089–104.
  • Chen EY, Hui CL, Chan RC, Dunn EL, Miao MY, Yeung WS, et al. 2005. A 3-year prospective study of neurological soft signs in first-episode schizophrenia. Schizophr Res 75:45–54.
  • Cuesta MJ, Peralta V, Zarzuela A, Calvo R, García M, Serrano F. 2002. Neurological soft-signs in psychosis: threshold criteria for discriminating normal controls and for predicting cognitive impairment. Schizophr Res 58:263–271.
  • Csomor PA, Stadler RR, Feldon J, Yee BK, Geyer MA, Vollenweider FX. 2008. Haloperidol differentially modulates prepulse inhibition and p50 suppression in healthy humans stratified for low and high gating levels. Neuropsychopharmacology 33:497–512.
  • Dazzan P, Lloyd T, Morgan KD, Zanelli J, Morgan C, Orr K, et al. 2008. Neurological abnormalities and cognitive ability in first-episode psychosis. Br J Psychiatry 193:197–202.
  • Dazzan P, Morgan KD, Orr KG, Hutchinson G, Chitnis X, Suckling J, et al. 2004. The structural brain correlates of neurological soft signs in AESOP first-episode psychoses study. Brain 127:143–153.
  • Dazzan P, Murray RM. 2002. Neurological soft signs in first-episode psychosis: a systematic review. Br J Psychiatry 43:50–57.
  • Duncan EJ, Bollini AM, Lewison B, Keyes M, Jovanovic T, Gaytan O, et al. 2006. Medication status affects the relationship of symptoms to prepulse inhibition of acoustic startle in schizophrenia. Psychiatry Res 145:137–145.
  • Evans LH, Gray NS, Snowden RJ. 2005. Prepulse inhibition of startle and its moderation by schizotypy and smoking. Psychophysiology 42:223–231.
  • Geyer MA, Swerdlow NR, Mansbach RS, Braff DL. 1990. Startle response models of sensorimotor gating and habituation deficits in schizophrenia. Brain Res Bull 25:485–498.
  • Giakoumaki SG, Bitsios P, Frangou S. 2006. The level of prepulse inhibition in healthy individuals may index cortical modulation of early information processing. Brain Res 1078:168–170.
  • Goff DC, Evins AE. 1998. Negative symptoms in schizophrenia: neurobiological models and treatment response. Harv Rev Psychiatry 6:59–77.
  • Goghari VM, Sponheim SR, MacDonald AW III. 2010. The functional neuroanatomy of symptom dimensions in schizophrenia: a qualitative and quantitative review of a persistent question. Neurosci Biobehav Rev 34:468–486.
  • Hammer TB, Oranje B, Skimminge A, Aggernæs B, Ebdrup BH, Glenthøj B, Baaré W. 2013. Structural brain correlates of sensorimotor gating in antipsychotic-naive men with first-episode schizophrenia. J Psychiatry Neurosci 38:34–42.
  • Hasenkamp W, Norrholm SD, Green A, Lewison B, Boshoven W, Keyes M, Duncan E. 2008. Differences in startle reflex and prepulse inhibition in European-Americans and African-Americans. Psychophysiology 45:876–882.
  • Hong LE, Wonodi I, Lewis J, Thaker GK. 2008. Nicotine effect on prepulse inhibition and prepulse facilitation in schizophrenia patients. Neuropsychopharmacology 33:2167–2174.
  • Kay SR, Fiszbein A, Opler LA, 1987. The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr Bull 13:261–276.
  • Koch M, Schnitzler HU 1997. The acoustic startle response in rats–circuits mediating evocation, inhibition and potentiation. Behavioural Brain Res 89:35–49.
  • Kumari V, Gray JA. 1999. Smoking withdrawal, nicotine dependence and prepulse inhibition of the acoustic startle reflex. Psychopharmacology 141:11–15.
  • Kumari V, Soni W, Sharma T 1999. Normalization of information processing deficits in schizophrenia with clozapine. Am J Psychiatry 156:1046–1051.
  • Kumari V, Antonova E, Zachariah E, Galea A, Aasen I, Ettinger U, et al. 2005. Structural brain correlates of prepulse inhibition of the acoustic startle response in healthy humans. Neuroimage 26:1052–1058.
  • Kumari V, Fannon D, Sumich AL, Sharma T. 2007a. Startle gating in antipsychotic-naïve first episode schizophrenia patients: one ear is better than two. Psychiatry Res 151:21–28.
  • Kumari V, Antonova E, Geyer MA, Fytche D, Williams SC, Sharma T. 2007b. A fMRI investigation of startle gating deficits in schizophrenia patients treated with typical or atypical antipsychotics. Int J Neuropsychopharmacol 10:463–477.
  • Kumari V, Fannon D, Geyer MA, Premkumar P, Antonova E, Simmons A, Kuipers E. 2008. Cortical grey matter volume and sensorimotor gating in schizophrenia. Cortex 44:1206–1214.
  • Kumari V. 2011. Sex differences and hormonal influences in human sensorimotor gating: implications for schizophrenia. Curr Top Behav Neurosci 8:141–154.
  • Maxwell ME. 1992. Family Interview for Genetic Studies (FIGS): Manual For FIGS, Clinical Neurogenetics Branch, Intramural Research Program, National Institute of Mental Health. Bethesda, MD.
  • Mayoral M, Bombín I, Zabala A, Robles O, Moreno D, Parellada M, et al. 2008. Neurological soft signs in adolescents with first episode psychosis: two-year follow up. Psychiatry Res 161:344–348.
  • Ludewig K, Geyer MA, Vollenweider FX. 2003. Deficits in prepulse inhibition and habituation in never-medicated, first-episode schizophrenia. Biol Psychiatry 54:121–128.
  • Mackeprang T, Kristiansen KT, Glenthoj BY. 2002. Effects of antipsychotics on prepulse inhibition of the startle response in drug-naive schizophrenic patients. Biol Psychiatry 52:863–873.
  • Meincke U, Mörth D, Voss T, Thelen B, Geyer MA, Gouzoulis-Mayfrank E. 2004. Prepulse inhibition of the acoustically evoked startle reflex in patients with an acute schizophrenic psychosis–a longitudinal study. Eur Arch Psychiatry Clin Neurosci 254:415–421.
  • Minassian A, Feifel D, Perry W. 2007. The relationship between sensorimotor gating and clinical improvement in acutely ill schizophrenia patients. Schizophrenia Res 89:225–231.
  • Mohr F, Hubmann W, Albus M, Franz U, Hecht S, Scherer J, et al. 2003. Neurological soft signs and neuropsychological performance in patients with first episode schizophrenia. Psychiatry Res 121:21–30.
  • Mueser KT, Nishith P, Tracy JI, DeGirolamo J, Molinaro M. 1995. Expectations and motives for substance use in schizophrenia. Schizophr Bull. 21:367–378.
  • Negash A, Kebede D, Alem A, Melaku Z, Deyessa N, Shibire T, et al. 2004. Neurological soft signs in bipolar I disorder patients. J Affect Disord 80:221–230.
  • Nelson HE. 1991. National Adult Reading Test, 2nd edition. Windsor, UK: NFER-Nelson.
  • Reichenberg A. 2010. The assessment of neuropsychological functioning in schizophrenia. Dialogues Clin Neurosci 12:383–392.
  • Sanders RD, Keshavan MS, Schooler NR. 1994. Neurological examination abnormalities in neuroleptic-naive patients with first-break schizophrenia: preliminary results. Am J Psychiatry 151:1231–1233.
  • Sartori G, Colombo L, Vallar G, Rusconi ML, Pinarello A. 1997. T.I.B.: Test di Intelligenza Breve per la valutazione del quoziente intellettivo attuale e pre-morboso. La Professione di Psicologo. 1:II–XXIV.
  • Smieskova R, Fusar-Poli P, Allen P, Bendfeldt K, Stieglitz RD, Drewe J, et al. 2010. Neuroimaging predictors of transition to psychosis–a systematic review and meta-analysis. Neurosci Biobehav Rev 34:1207–1222.
  • Spitzer RL, Williams JBW, Gibbon M, First MB. 1993. SCID Intervista strutturata per il DSMIII-R (Italian version by Fava M, Guaraldi GP, Mazzi F, Rigatelli M.) Organizzazioni Speciali, Firenze.
  • Swerdlow NR, Geyer MA, Braff DL. 2001. Neural circuit regulation of prepulse inhibition of startle in the rat: current knowledge and future challenges. Psychopharmacology 156:194–215.
  • Swerdlow NR, Talledo JA, Braff DL. 2005. Startle modulation in Caucasian-Americans and Asian-Americans: a prelude to genetic/endophenotypic studies across the ’Pacific Rim’. Psychiatr Genet 15:61–65.
  • Thaker G. 2008. Psychosis endophenotypes in schizophrenia and bipolar disorder. Schizophr Bull 34:720–721.
  • Tosato S, Dazzan P. 2005. The psychopathology of schizophrenia and the presence of neurological soft signs: a review. Curr Opin Psychiatry 18:285–288.
  • Venkatasubramanian G, Jayakumar PN, Gangadhar BN, Keshavan MS. 2008. Neuroanatomical correlates of neurological soft signs in antipsychotic-naive schizophrenia. Psychiatry Res 164:215–222.
  • Venkatasubramanian G, Latha V, Gangadhar BN, Janakiramaiah N, Subbakrishna DK, Jayakumar PN, Keshavan MS. 2003. Neurological soft signs in never-treated schizophrenia. Acta Psychiatr Scand 108:144–146.
  • Whitty P, Clarke M, McTigue O, Browne S, Gervin M, Kamali M, et al. 2006. Diagnostic specificity and predictors of neurological soft signs in schizophrenia, bipolar disorder and other psychoses over the first 4 years of illness. Schizophr Res 86:110–117.
  • World Health Organization. 1992. Schedules for Clinical Assessment in Neuropsychiatry (Version 1.0). Geneva, CH: WHO.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.